Delivering the Power of J.P. Morgan to Life Sciences Companies
Whether the end goal is FDA approval, sale or IPO, J.P. Morgan works seamlessly with life sciences companies throughout their life cycle and across all day-to-day operational needs.
J.P. Morgan has a long history of supporting companies within the healthcare and life sciences industries, recognizing the opportunity and potential for good that these organizations represent. Four leaders—Peter Meath, Sam Quinn, Lisa Gill and Christine Leong Connors—across the Commercial Bank, Private Bank and Investment Bank, discuss their involvement in and commitment to the life sciences industry. As companies face a constant state of disruption and increasingly complex FDA approval environment, partnering with J.P. Morgan allows them to stay ahead, regardless of what the next phase of their life cycle looks like.